Abstract
Grand challenges in stem cell treatments.
Highlights
Stem cells mainly include embryonic stem cells (ESC), pluripotent stem cells, Epiblast-derived stem cells (Epi-SC), and adult tissue stem cells
There are ethical issues when using human embryos, and ESC transplants into mouse models can result in malignant tumors
Human ESC lines derived from single blastomeres have been reported (Klimanskaya et al, 2006)
Summary
Stem cells mainly include embryonic stem cells (ESC), pluripotent stem cells (iPS), Epiblast-derived stem cells (Epi-SC), and adult tissue stem cells. There are ethical issues when using human embryos, and ESC transplants into mouse models can result in malignant tumors. Further challenges facing research in the use of ESC are how to reduce contamination, and prevent cancer risk.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.